167 related articles for article (PubMed ID: 15616316)
21. CMY-2, CMY-8b, and DHA-1 plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from a university hospital, Thailand.
Singtohin S; Chanawong A; Lulitanond A; Sribenjalux P; Auncharoen A; Kaewkes W; Songsri J; Pienthaweechai K
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):271-7. PubMed ID: 20851550
[TBL] [Abstract][Full Text] [Related]
22. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada.
Boyd DA; Tyler S; Christianson S; McGeer A; Muller MP; Willey BM; Bryce E; Gardam M; Nordmann P; Mulvey MR
Antimicrob Agents Chemother; 2004 Oct; 48(10):3758-64. PubMed ID: 15388431
[TBL] [Abstract][Full Text] [Related]
23. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and molecular characterization of AmpC-producing clinical isolates of Escherichia coli from southeastern Iran.
Shayan S; Bokaeian M; Shahraki S
Microb Drug Resist; 2014 Apr; 20(2):104-7. PubMed ID: 24224496
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study.
Simner PJ; Zhanel GG; Pitout J; Tailor F; McCracken M; Mulvey MR; Lagacé-Wiens PR; Adam HJ; Hoban DJ;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):326-34. PubMed ID: 21353961
[TBL] [Abstract][Full Text] [Related]
26. [A new member of CMY type cephalosporinase prevailing in Escherichia coli].
Guan XZ; Liu YN; Luo YP; She DY; Zhou G; Chen LA; Xu YP
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1872-5. PubMed ID: 15631796
[TBL] [Abstract][Full Text] [Related]
27. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
Tan TY; Ng SY; Teo L; Koh Y; Teok CH
J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079
[TBL] [Abstract][Full Text] [Related]
28. Characterisation of CTX-M and AmpC genes in human isolates of Escherichia coli identified between 1995 and 2003 in England and Wales.
Hopkins KL; Batchelor MJ; Liebana E; Deheer-Graham AP; Threlfall EJ
Int J Antimicrob Agents; 2006 Sep; 28(3):180-92. PubMed ID: 16879949
[TBL] [Abstract][Full Text] [Related]
29. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital.
Mammeri H; Eb F; Berkani A; Nordmann P
J Antimicrob Chemother; 2008 Mar; 61(3):498-503. PubMed ID: 18250231
[TBL] [Abstract][Full Text] [Related]
30. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
Palasubramaniam S; Muniandy S; Navaratnam P
J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
[TBL] [Abstract][Full Text] [Related]
31. [Expression of high-level cephalosporinase due to mutation in the AmpC attenuator of a clinical Escherichia coli strain].
Guan XZ; Liu YN; Luo YP; She DY; Lu SJ; Zhou G; Chen LA
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):600-4. PubMed ID: 16681904
[TBL] [Abstract][Full Text] [Related]
32. Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli.
Odeh R; Kelkar S; Hujer AM; Bonomo RA; Schreckenberger PC; Quinn JP
Clin Infect Dis; 2002 Jul; 35(2):140-5. PubMed ID: 12087519
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from horses.
Vo AT; van Duijkeren E; Fluit AC; Gaastra W
Vet Microbiol; 2007 Oct; 124(3-4):248-55. PubMed ID: 17521833
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan.
Matsumura Y; Yamamoto M; Higuchi T; Komori T; Tsuboi F; Hayashi A; Sugimoto Y; Hotta G; Matsushima A; Nagao M; Takakura S; Ichiyama S
Int J Antimicrob Agents; 2012 Aug; 40(2):158-62. PubMed ID: 22743014
[TBL] [Abstract][Full Text] [Related]
35. Occurrence of plasmidic AmpC type beta-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004).
Deshpande LM; Jones RN; Fritsche TR; Sader HS
Int J Antimicrob Agents; 2006 Dec; 28(6):578-81. PubMed ID: 17112706
[TBL] [Abstract][Full Text] [Related]
36. Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.
Mammeri H; Poirel L; Nordmann P
J Antimicrob Chemother; 2007 Sep; 60(3):490-4. PubMed ID: 17586561
[TBL] [Abstract][Full Text] [Related]
37. Characterization of antimicrobial resistance and molecular determinants of beta-lactamase in Escherichia coli isolated from chickens in China during 1970-2007.
Li L; Jiang ZG; Xia LN; Shen JZ; Dai L; Wang Y; Huang SY; Wu CM
Vet Microbiol; 2010 Aug; 144(3-4):505-10. PubMed ID: 20207509
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of amoxycillin-clavulanate in an experimental model of murine pneumonia caused by AmpC-non-hyperproducing clinical isolates of Escherichia coli resistant to cefoxitin.
Docobo-Pérez F; Fernández-Cuenca F; Pachón-Ibáñez ME; Pascual A; Pichardo C; Martínez-Martínez L; Pachón J
Clin Microbiol Infect; 2008 Jun; 14(6):582-7. PubMed ID: 18294246
[TBL] [Abstract][Full Text] [Related]
39. Detection of AmpC beta-lactamase in Escherichia coli: comparison of three phenotypic confirmation assays and genetic analysis.
Peter-Getzlaff S; Polsfuss S; Poledica M; Hombach M; Giger J; Böttger EC; Zbinden R; Bloemberg GV
J Clin Microbiol; 2011 Aug; 49(8):2924-32. PubMed ID: 21653764
[TBL] [Abstract][Full Text] [Related]
40. Characterization of plasmids encoding CMY-2 AmpC beta-lactamases from Escherichia coli in Canadian intensive care units.
Baudry PJ; Mataseje L; Zhanel GG; Hoban DJ; Mulvey MR
Diagn Microbiol Infect Dis; 2009 Dec; 65(4):379-83. PubMed ID: 19775846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
